Oak Family Advisors LLC Purchases 1,208 Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Oak Family Advisors LLC boosted its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 1.9% during the 2nd quarter, HoldingsChannel reports. The fund owned 64,925 shares of the company’s stock after buying an additional 1,208 shares during the quarter. Oak Family Advisors LLC’s holdings in Bioceres Crop Solutions were worth $728,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Activest Wealth Management bought a new position in Bioceres Crop Solutions during the first quarter valued at about $30,000. Cape Investment Advisory Inc. bought a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at approximately $33,000. Oppenheimer & Co. Inc. bought a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at approximately $139,000. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at approximately $212,000. Finally, One Degree Advisors Inc bought a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at approximately $291,000. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Price Performance

NASDAQ BIOX traded down $0.20 during trading hours on Thursday, reaching $9.92. 16,234 shares of the company’s stock were exchanged, compared to its average volume of 56,762. The firm has a fifty day moving average of $10.72 and a 200-day moving average of $11.77. Bioceres Crop Solutions Corp. has a one year low of $9.71 and a one year high of $14.05. The company has a current ratio of 1.22, a quick ratio of 0.83 and a debt-to-equity ratio of 0.29. The stock has a market cap of $622.95 million, a PE ratio of 992.00 and a beta of 0.50.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Wednesday, May 29th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.02). Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. The firm had revenue of $83.98 million for the quarter, compared to analyst estimates of $88.80 million. On average, equities research analysts predict that Bioceres Crop Solutions Corp. will post 0.35 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on BIOX shares. Roth Mkm started coverage on Bioceres Crop Solutions in a research note on Tuesday, July 2nd. They issued a “buy” rating and a $15.00 price objective on the stock. Canaccord Genuity Group reiterated a “buy” rating and issued a $17.00 price objective on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Finally, Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Three research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Bioceres Crop Solutions has a consensus rating of “Buy” and an average target price of $19.00.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.